[1]张思维,郑荣寿,孙可欣,等.2016年中国恶性肿瘤分地区发病和死亡估计:基于人群的肿瘤登记数据分析[J].中国肿瘤,2023,32(05):321-332.
ZHANG SW,ZHENG RS,SUN KX,et al.2016 estimation of incidence and death of malignant tumors in China by region:analysis of population based tumor registration data [J].China Cancer,2023,32(05):321-332.
[2]WENG S,YUAN Y,WANG X,et al.Updates in version 2020 of CSCO guidelines for colorectal cancer from version 2019[J].Chin J Cancer Res,2020,32(3):403-407.
[3]SINGH AK,MALVIYA R.Coagulation and inflammation in cancer:Limitations and prospects for treatment[J].Biochimica Et Biophysica Acta Reviews On Cancer,2022,1877(3):188727.
[4]SCHLESINGER M.Role of platelets and platelet receptors in cancer metastasis[J].Journal of Hematology & Oncology,2018,11(1):125.
[5]CHEN H,WU X,WEN Z,et al.The clinicopathological and prognostic value of NLR,PLR and MLR in non-muscular invasive bladder cancer[J].Archivos Espanoles de Urologia,2022,75(5):467-471.
[6]MANDALIYA H,JONES M,OLDMEADOW C,et al.Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC):neutrophil to lymphocyte ratio (NLR),lymphocyte to monocyte ratio (LMR),platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)[J].Translational Lung Cancer Research,2019,8(6):886-894.
[7]ZHANG Y,LIU N,LIU C,et al.High fibrinogen and platelets correlate with poor survival in gastric cancer patients[J].Annals of Clinical and Laboratory Science,2020,50(4):457-462.
[8]TRANUM BL,HAUT A.Thrombocytosis:platelet kinetics in neoplasia[J].The Journal of Laboratory and Clinical Medicine,1974,84(5):615-619.
[9]IKEDA M,FURUKAWA H,IMAMURA H,et al.Poor prognosis associated with thrombocytosis in patients with gastric cancer[J].Annals of Surgical Oncology,2002,9(3):287-291.
[10]HAEMMERLE M,STONE RL,MENTER DG,et al.The platelet lifeline to cancer:challenges and opportunities[J].Cancer Cell,2018,33(6):965-983.
[11]NIESWANDT B,HAFNER M,ECHTENACHER B,et al.Lysis of tumor cells by natural killer cells in mice is impeded by platelets[J].Cancer Research,1999,59(6):1295-1300.
[12]HAN X,GUO B,LI Y,et al.Tissue factor in tumor microenvironment:a systematic review[J].Journal of Hematology & Oncology,2014,7:54.
[13]PLANTUREUX L,MEGE D,CRESCENCE L,et al.The interaction of platelets with colorectal cancer cells inhibits tumor growth but promotes metastasis[J].Cancer Research,2020,80(2):291-303.
[14]LI B,ZHOU P,LIU Y,et al.Platelet-to-lymphocyte ratio in advanced cancer:review and meta-analysis[J].Clinica Chimica Acta International Journal of Clinical Chemistry,2018,483:48-56.
[15]ZHOU K,CAO J,LIN H,et al.Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy:A systematic review and meta-analysis[J].Frontiers In Oncology,2022,12:962173.
[16]LI W,TAO L,LU M,et al.Prognostic role of platelet to lymphocyte ratio in pancreatic cancers:A meta-analysis including 3028 patients[J].Medicine,2018,97(8):e9616.
[17]徐小峰,戴宏宇,乔建兵,等.外周血NLR和PLR评估晚期非小细胞肺癌一线含铂双药化疗疗效和预后的价值[J].现代肿瘤医学,2020,28(15):2627-2631.
XU XF,DAI HY,QIAO JB,et al.Effect of the NLR and PLR on the response of first line platinum-based chemotherapy and the prognosis in advanced NSCLC[J].Modern Oncology,2020,28(15):2627-2631.
[18]郭英,田勍,邹长鹏,等.外周血血小板与淋巴细胞比值和微量元素评估胃癌术后复发转移的价值[J].现代肿瘤医学,2022,30(14):2571-2575.
GUO Y,TIAN Q,ZOU CP,et al.The value of platelet-to-lymphocyte ratio and trace elements in evaluating postoperative recurrence and metastasis of gastric cancer[J].Modern Oncology,2022,30(14):2571-2575.
[19]焦若男,魏新,赵思,等.血小板与淋巴细胞比率对胃癌预后影响的Meta分析[J].现代肿瘤医学,2020,28(11):1903-1909.
JIAO RN,WEI X,ZHAO S,et al.Prognostic value of platelet-lymphocyte ratio in gastric cancer:A Meta-analysis[J].Modern Oncology,2020,28(11):1903-1909.
[20]KATTULA S,BYRNES JR,WOLBERG AS.Fibrinogen and fibrin in hemostasis and thrombosis[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2017,37(3):e13-e21.
[21]SHARMA BK,MUREB D,MURAB S,et al.Fibrinogen activates focal adhesion kinase (FAK) promoting colorectal adenocarcinoma growth[J].Journal of Thrombosis and Haemostasis,2021,19(10):2480-2494.
[22]LIU M,YANG J,WAN L,et al.Elevated pretreatment fibrinogen-to-lymphocyte percentage ratio predict tumor staging and poor survival in non-small cell lung cancer patients with chemotherapy or surgery combined with chemotherapy[J].Cancer Management and Research,2021,13:4921-4933.
[23]QIAN X,CAI J,QI Q,et al.Preoperative fibrinogen is associated with the clinical survival of primary liver cancer patients and promotes hepatoma metastasis via the PTEN/AKT/mTOR pathway[J].Heliyon,2023,9(6):e16696.
[24]XU J,AN S,LU Y,et al.Preoperative alpha fetoprotein,total bilirubin,fibrinogen,albumin,and lymphocytes predict postoperative survival in hepatocellular carcinoma[J].Cancer Medicine,2023,12(12):13319-13328.